Cerner Corp Stock Research

CERN Stock Price

CERN RSI Chart

CERN Valuation

Market Cap

27.9B

Price/Earnings (Trailing)

47.36

Price/Sales (Trailing)

4.81

EV/EBITDA

19.86

Price/Free Cashflow

19.38

CERN Price/Sales (Trailing)

CERN Profitability

Free Cashflow Yield

5.16%

CERN Fundamentals

CERN Revenue

CERN Earnings

Price Action

Last 7 days

0.1%

Last 30 days

1.0%

Last 90 days

2.3%

Trailing 12 Months

20.8%

CERN Financial Health

CERN Investor Care

Peers (Alternatives to Cerner)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	439.0B	324.2B	-0.88%	-8.54%	21.82	1.35	12.71%	16.40%
CERN	27.9B	-	0.98%	20.75%	47.36	4.81	-	-
VEEV	27.8B	2.1B	8.14%	-16.29%	70.25	13.4	17.88%	-8.53%
MID-CAP
CHNG	9.0B	3.5B	11.88%	31.28%	-116.8	2.57	7.15%	-34.72%
TDOC	4.0B	2.4B	-7.78%	-66.57%	-0.29	1.65	18.41%	-3085.58%
OMCL	2.5B	1.3B	3.53%	-57.31%	446.52	1.95	14.48%	-92.74%
SMALL-CAP
PHR	1.6B	262.3M	-16.17%	5.00%	-8.79	6.19	33.16%	-131.28%
MDRX	1.4B	837.2M	-22.28%	-42.42%	23.26	1.68	3.88%	-92.18%
NXGN	1.1B	625.9M	-5.47%	-18.51%	49.3	1.81	6.21%	3223.77%
SLP	885.1M	53.5M	14.54%	-12.33%	82.7	16.56	10.94%	3.61%
CCRN	804.5M	2.8B	-16.22%	4.04%	4.27	0.29	67.39%	42.77%
HSTM	800.9M	266.8M	2.11%	29.65%	66.24	3	3.94%	106.86%
HCAT	628.9M	276.2M	-18.48%	-57.25%	-4.58	2.28	14.18%	10.32%
CPSI	429.9M	317.4M	-0.27%	-12.77%	22.93	1.35	16.07%	16.08%

Financials for Cerner

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Revenue	0.7%	5,807	5,765	5,708	5,608	5,482
S&GA Expenses	-0.6%	518	521	491	486	464
Costs and Expenses	0.2%	5,065	5,057	5,041	4,972	4,748
EBITDA	2.3%	1,451	1,418	-	-	-
EBITDA Margin	1.6%	0.25*	0.25*	-	-	-
Earnings Before Taxes	4.7%	732	699	663	903	1,027
EBT Margin	3.9%	0.13*	0.12*	-	-	-
Net Income	6.1%	589	556	522	703	805
Net Income Margin	5.3%	0.10*	0.10*	-	-	-
Free Cahsflow	-2.8%	1,440	1,482	-	-	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Assets	-0.8%	7,374	7,434	7,543	7,721	7,908
Current Assets	0.8%	2,468	2,449	2,440	2,541	3,055
Cash Equivalents	20.3%	710	590	460	246	998
Inventory	-1.6%	28.00	28.00	25.00	20.00	30.00
Net PPE	-2.8%	1,610	1,656	1,718	1,769	1,803
Goodwill	-0.1%	1,130	1,131	1,127	1,130	912
Liabilities	-7.7%	3,466	3,754	3,703	3,695	3,596
Current Liabilities	-15.2%	1,379	1,626	1,551	1,543	1,463
LT Debt, Current	-100.0%	-	225	225	225	225
LT Debt, Non Current	0.0%	1,611	1,611	1,611	1,611	1,611
Shareholder's Equity	6.2%	3,909	3,680	3,840	4,026	4,312
Retained Earnings	1.9%	6,877	6,752	6,657	6,547	6,581
Additional Paid-In Capital	3.5%	2,812	2,717	2,599	2,510	2,368
Accumulated Depreciation	-	1,934	-	-	-	-
Shares Outstanding	-0.9%	293	296	301	305	-
Float	-	20,900	-	-	-	-

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1
Cashflow From Operations	-4.3%	1,696	1,772	1,767	1,714	1,604
Share Based Compensation	-7.2%	182	196	201	183	167
Cashflow From Investing	23.3%	-559	-729	-909	-1,327	-846
Cashflow From Financing	-34.0%	-1,413	-1,054	-809	-414	-48.42
Dividend Payments	4.4%	279	267	257	246	233
Buy Backs	-22.8%	1,158	1,500	1,232	857	449

Risks for CERN

What is the probability of a big loss on CERN?

56.1%

Probability that Cerner stock will be more than 20% underwater in next one year

1.1%

Probability that Cerner stock will be more than 30% underwater in next one year.

Probability that Cerner stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CERN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cerner was unfortunately bought at previous high price.

Drawdowns

Returns for CERN

Cumulative Returns on CERN

9.5%

10-Year Cumulative Returns

5.9%

7-Year Cumulative Returns

7.6%

5-Year Cumulative Returns

10.5%

3-Year Cumulative Returns

What are the long-term rolling returns for CERN?

FIve years rolling returns for Cerner.

Annualized Returns

Which funds bought or sold CERN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-02-09	HUNTINGTON NATIONAL BANK	unchanged	-	95.00	95.00	-%
2023-02-07	IFP Advisors, Inc	sold off	-100	-549,000	-	-%
2022-08-15	Frontier Wealth Management LLC	sold off	-100	-757,000	-	-%
2022-07-28	Private Capital Group, LLC	sold off	-100	-31,000	-	-%
2022-07-20	IBM Retirement Fund	sold off	-100	-441,000	-	-%
2022-05-31	Mid-American Wealth Advisory Group, Inc.	reduced	-0.56	-	330,000	0.26%
2022-05-23	SPRING CREEK CAPITAL LLC	new	-	65,492,000	65,492,000	2.59%
2022-05-16	Parametric Portfolio Associates LLC	added	7.55	9,646,000	125,134,000	0.07%
2022-05-16	Amalgamated Financial Corp.	new	-	7,659,000	7,659,000	0.06%
2022-05-16	Tibra Equities Europe Ltd	new	-	21,185,000	21,185,000	23.44%

Latest Funds Activity

Are funds buying CERN calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own CERN

No. of Funds

Cerner News

Schedule 13G FIlings of Cerner

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2022	vanguard group inc	10.81%	31,586,238	SC 13G/A
Feb 07, 2022	blackrock inc.	8.3%	24,425,920	SC 13G/A
Mar 10, 2021	bank of new york mellon corp	3.18%	9,742,229	SC 13G/A
Feb 10, 2021	vanguard group inc	10.65%	32,645,742	SC 13G/A
Feb 01, 2021	bank of new york mellon corp	5.21%	15,965,148	SC 13G
Jan 29, 2021	blackrock inc.	8.2%	25,096,524	SC 13G/A
Feb 12, 2020	vanguard group inc	10.65%	33,451,876	SC 13G/A
Feb 05, 2020	blackrock inc.	7.5%	23,516,312	SC 13G/A

CERN Fair Value

Latest Insider Trading transactions for CERN

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2022-06-08	WISE R HALSEY	back to issuer	-302,860	95.00	-3,188	-
2022-06-08	Granger Elder	back to issuer	-513,285	95.00	-5,403	-
2022-06-08	Battaglioli Michael R.	back to issuer	-324,140	95.00	-3,412	svp & chief accounting officer
2022-06-08	ZOLLARS WILLIAM D	back to issuer	-349,600	95.00	-3,680	-
2022-06-07	Labat Jerome	sold	-2,081,360	95.00	-21,909	evp & chief technology officer
2022-06-07	Dalton Travis	sold	-43,130	95.00	-454	evp & chief client & serv. off
2022-06-07	Labat Jerome	sold	-3,515	95.00	-37.00	evp & chief technology officer
2022-06-07	Dalton Travis	sold	-51,205	95.00	-539	evp & chief client & serv. off
2022-06-07	Daniels Mitchell E	sold	-3,558,700	95.00	-37,460	-
2022-06-07	Erceg Mark J	sold	-4,170,980	95.00	-43,905	exec. vp & cfo

About Cerner

David T. Feinberg

www.cerner.com

25200

Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.

CERN Income Statement

2022-03-31

Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues	$ 1,429,801	$ 1,387,778
Costs and expenses:
Costs of revenue	243,848	230,656
Sales and client service	612,997	622,176
Software development (Includes amortization of $65,206 and $64,850, respectively)	195,091	192,327
General and administrative	109,279	112,365
Amortization of acquisition-related intangibles	16,602	12,196
Total costs and expenses	1,177,817	1,169,720
Operating earnings	251,984	218,058
Other income, net	26	1,206
Earnings before income taxes	252,010	219,264
Income taxes	(45,881)	(47,012)
Net earnings	$ 206,129	$ 172,252
Basic earnings per share	$ 0.70	$ 0.57
Diluted earnings per share	$ 0.70	$ 0.56
Basic weighted average shares outstanding	293,412	304,731
Diluted weighted average shares outstanding	296,336	308,031

CERN Balance Sheet

2022-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 709,532	$ 589,847
Short-term investments	171,180	252,622
Receivables, net	1,178,037	1,161,361
Inventory	27,704	28,159
Prepaid expenses and other	381,404	417,465
Total current assets	2,467,857	2,449,454
Property and equipment, net	1,610,496	1,656,171
Right-of-use assets	76,474	82,940
Software development costs, net	1,003,806	1,000,357
Goodwill	1,129,539	1,131,121
Intangible assets, net	434,900	458,482
Long-term investments	456,398	461,984
Other assets	194,761	193,649
Total assets	7,374,231	7,434,158
Current liabilities:
Accounts payable	359,562	329,582
Current installments of long-term debt	0	225,000
Deferred revenue	456,929	531,234
Accrued payroll and tax withholdings	284,145	317,092
Other current liabilities	278,236	223,350
Total current liabilities	1,378,872	1,626,258
Long-term Debt	1,611,303	1,611,256
Deferred income taxes	362,236	395,177
Other liabilities	113,301	121,005
Total liabilities	3,465,712	3,753,696
Shareholders' Equity:
Common stock, $0.01 par value, 500,000,000 shares authorized, 381,357,862 shares issued at March 31, 2022 and 380,232,975 shares issued at December 31, 2021	3,814	3,802
Additional paid-in capital	2,811,612	2,717,244
Retained earnings	6,877,111	6,751,692
Treasury stock, 87,383,166 shares at March 31, 2022 and December 31, 2021	(5,664,718)	(5,664,718)
Accumulated other comprehensive loss, net	(119,300)	(127,558)
Total shareholders' equity	3,908,519	3,680,462
Total liabilities and shareholders' equity	$ 7,374,231	$ 7,434,158
Common stock, par value	$ 0.01
Common Stock, Shares Authorized	500,000,000
Common stock, shares issued	381,357,862	380,232,975
Treasury Stock, Shares	87,383,166